ClinicalTrials.govpublic full text
A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
adenocarcinoma, stomach cancer, mfolfox6, pembrolizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886410
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.